Dental sleep group pens letter to FDA over consumer protections for oral appliances
By Ariana Portalatin
Originally at beckersdental.com
Summary & scoring by The Bell Brief (Dr. Jennifer Bell) using the Drill-Down Protocol (Drill-Down Score) — not the original publisher.
Why it matters for dental
Dental practice owners and sleep-medicine providers face rising compliance risk and patient-harm exposure when direct-to-consumer oral appliances for snoring and OSA reach the market without dentist supervision; the AADSM’s FDA letter urges stronger consumer protections that could reshape device prescribing and billing workflows.
Key points
- The American Academy of Dental Sleep Medicine sent an FDA letter on citing mail-order appliances marketed without dental oversight and subsequent reports of faulty devices and patient harm.
- The AADSM letter references new research showing increased FDA Manufacturer and User Facility Device Experience database entries for direct-to-consumer oral appliances in recent years.
- The AADSM requested a dedicated FDA consumer-protection webpage for intraoral snoring and obstructive sleep-apnea devices, modeled after the agency’s existing clear-aligner guidance page.
- The AADSM webpage proposal specifies language on prescription requirements, licensed supervision, and the lack of authorization for direct-to-consumer oral appliances.
Who should care
Read the original on Becker's Dental + DSO Review
Full reporting and any paywall content live on beckersdental.com. We summarize and score; we do not republish.
Related
- ·Regulatory
Dentists Win at the Supreme Court, But Conduent Gets Tossed a Bone
- ·Regulatory
Texas Department of Insurance launches Insurance Fraud Task Force to clamp down on fraud and protect Texas consumers
- ·Regulatory
FDA recalls 4 million tubes of fluoride toothpaste
- ·Regulatory
Coast Dental Services agrees to pay $3.8M to settle class-action lawsuit